Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
19/03/2026 11:56
March 19 (Reuters) - Aptose Biosciences Inc APS.TO: LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS APTOSE BIOSCIENCES SHAREHOLDERS VOTE “FOR” PROPOSED PLAN OF ARRANGEMENT WITH HANMI PHARMACEUTICAL Source text: ID:nGNXYgV0t Further company coverage: APS.TO ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting